FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816 P/E (TTM) :11.44
ISIN Demat:INE987B01026 Div & Yield %:0.63 EPS (TTM) :83.75
Book Value (RS) :461.79599 Market Cap (Rs Cr.):17156.04 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 528.80 407.60 29.74
Other Income 55.30 168.00 -67.08
PBIDT 175.60 197.40 -11.04
Interest 8.30 3.40 144.12
PBDT 167.30 194.00 -13.76
Depreciation 42.10 43.70 -3.66
PBT 125.20 150.30 -16.70
Tax 26.20 27.90 -6.09
Deferred Tax -7.90 -2.50 0.00
PAT 106.90 124.90 -14.41

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)